ZA200100377B - Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method of assessing antitumor substance containing amygdalin. - Google Patents

Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method of assessing antitumor substance containing amygdalin.

Info

Publication number
ZA200100377B
ZA200100377B ZA200100377A ZA200100377A ZA200100377B ZA 200100377 B ZA200100377 B ZA 200100377B ZA 200100377 A ZA200100377 A ZA 200100377A ZA 200100377 A ZA200100377 A ZA 200100377A ZA 200100377 B ZA200100377 B ZA 200100377B
Authority
ZA
South Africa
Prior art keywords
amygdalin
substance
antitumor
assessing
contained
Prior art date
Application number
ZA200100377A
Other languages
English (en)
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of ZA200100377B publication Critical patent/ZA200100377B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200100377A 2000-01-17 2001-01-12 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method of assessing antitumor substance containing amygdalin. ZA200100377B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000008337A JP2001199892A (ja) 2000-01-17 2000-01-17 アミグダリン含有物の抗腫瘍活性強化方法、抗腫瘍活性強化アミグダリン含有物を含む組成物、アミグダリン含有物処理の抗腫瘍有効性評価方法、およびアミグダリン含有物の抗腫瘍有効性評価方法

Publications (1)

Publication Number Publication Date
ZA200100377B true ZA200100377B (en) 2001-07-18

Family

ID=18536624

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200100377A ZA200100377B (en) 2000-01-17 2001-01-12 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method of assessing antitumor substance containing amygdalin.

Country Status (19)

Country Link
US (2) US20010009903A1 (it)
JP (1) JP2001199892A (it)
KR (1) KR20010076279A (it)
CN (1) CN1319431A (it)
AU (1) AU1502101A (it)
CA (1) CA2331167A1 (it)
DE (1) DE10101543A1 (it)
DK (1) DK200100086A (it)
ES (1) ES2166741B1 (it)
FR (1) FR2805746A1 (it)
GB (1) GB2360211A (it)
ID (1) ID29765A (it)
IL (1) IL140900A0 (it)
IS (1) IS5804A (it)
IT (1) ITTO20010028A1 (it)
NL (1) NL1017117C2 (it)
NO (1) NO20010049L (it)
SE (1) SE0100083L (it)
ZA (1) ZA200100377B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3256746B2 (ja) * 2000-03-02 2002-02-12 高知医科大学長 細胞線維化を抑制する組成物及び枇杷核エキスの調製方法
KR100470294B1 (ko) * 2002-08-20 2005-02-05 (주) 한약마을 도인 또는 행인으로부터 아미그달린을 효과적으로 얻는추출방법
GB0402728D0 (en) * 2004-02-07 2004-03-10 Pharming Ltd Pesticides
JP2006197928A (ja) * 2004-12-22 2006-08-03 Yamaguchi Prefecture タケノコ麹及びその製造方法並びにタケノコ醗酵食品及びその製造方法
JP4974116B2 (ja) * 2005-06-27 2012-07-11 国立大学法人 鹿児島大学 ビワ葉抽出物を含有する飲食品及び医薬品
CN101190019B (zh) * 2006-11-21 2011-03-09 马玉林 杏仁酱及其制备方法
RU2348079C1 (ru) * 2007-09-05 2009-02-27 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ и устройство для экспериментального моделирования активации процессов перекисного окисления липидов биологических мембран
CN107400150A (zh) * 2017-08-16 2017-11-28 黄山市歙县绿色三潭枇杷生物科技有限公司 一种从枇杷核中提取苦杏仁苷的方法
CN113521084A (zh) * 2021-08-13 2021-10-22 唐秀全 一种苦杏仁苷含片及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226228A (ja) * 1985-07-26 1987-02-04 Echigo Yakusou:Kk 粉末よもぎの製造法
JPS6379834A (ja) * 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
JPH0193508A (ja) * 1987-06-09 1989-04-12 Sugiura Shinyaku Kaihatsu Kenkyusho:Kk ス−パ−オキシドディスムタ−ゼを高濃度に含有するキュウカンバエキス及びその製法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
JPH06227998A (ja) * 1993-01-28 1994-08-16 Sanji Kumai ニトリル配糖体を含有する生薬エキスの制癌活性
JPH07165589A (ja) * 1993-12-13 1995-06-27 Tsumura & Co 脳機能改善剤
JPH07188044A (ja) * 1993-12-27 1995-07-25 Asahi Breweries Ltd 抗活性酸素作用組成物の製造法
JPH08140613A (ja) * 1994-11-17 1996-06-04 Toshiyuki Ota 食 品
GB2314800A (en) * 1996-12-05 1998-01-14 Henry Berry & Co Ltd Component assembly machine
JPH10298099A (ja) * 1997-04-23 1998-11-10 Kozo Niwa 細胞賦活組成物

Also Published As

Publication number Publication date
NO20010049D0 (no) 2001-01-04
ID29765A (id) 2001-10-11
NO20010049L (no) 2001-07-18
US20010009903A1 (en) 2001-07-26
DK200100086A (da) 2001-07-18
DE10101543A1 (de) 2001-07-19
IS5804A (is) 2001-07-17
CN1319431A (zh) 2001-10-31
IL140900A0 (en) 2002-02-10
ITTO20010028A1 (it) 2002-07-16
ES2166741A1 (es) 2002-04-16
NL1017117C2 (nl) 2003-09-30
KR20010076279A (ko) 2001-08-11
NL1017117A1 (nl) 2001-07-19
SE0100083L (sv) 2001-07-18
US20020098252A1 (en) 2002-07-25
FR2805746A1 (fr) 2001-09-07
ITTO20010028A0 (it) 2001-01-16
ES2166741B1 (es) 2003-11-16
SE0100083D0 (sv) 2001-01-12
GB0101181D0 (en) 2001-02-28
CA2331167A1 (en) 2001-07-17
JP2001199892A (ja) 2001-07-24
AU1502101A (en) 2001-07-19
GB2360211A (en) 2001-09-19

Similar Documents

Publication Publication Date Title
ZA200202449B (en) Use of retigabin for treating neuropathic pain.
EP1446087A4 (en) METHOD FOR TREATING NON-NEUROPATHIC PAIN
PT1231887E (pt) Método e composição para o tratamento de cicatrizes
EG24978A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment.
IL157163A0 (en) Composition, apparatus and method for skin rejuvenation
EP1430873A4 (en) CAPILLARY TREATMENT AGENT COMPOSITION AND PROCESS FOR PREPARING THE SAME
ZA200202996B (en) Hair treatment compositions comprising particulate substances.
ZA99526B (en) Moistened cosmetic eye treatment pads.
GB0110288D0 (en) Composition and treatment method
WO2003053383A3 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
MXPA01009415A (es) COMPOSICION DE ACIDO ASCORBICO Y METODO PARA TRATAMIENTO DE PIEL DAnADA O ENVEJECIDA.
ZA200309733B (en) Method and apparatus for distributing treatment agents.
ZA200100377B (en) Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method of assessing antitumor substance containing amygdalin.
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
ZA200200606B (en) Method of hair treatment using organic amino compounds.
MXPA01010476A (es) Metodo y aparato para prevenir la caries dental.
IL161073A0 (en) Composition and method for treating diabetes
GB9820631D0 (en) Hair treatment composition, method and use
MXPA03004449A (es) Metodo cosmetico para tratar la piel.
EP1250145A4 (en) PEPTIDES DERIVED FROM ONCOGENE C-SKI FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
ZA99253B (en) Treatment of waxes.
GB9814269D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes
ZA200007396B (en) Method of treatment.
IL150202A0 (en) Method and composition for the treatment of pain